Literature DB >> 22576164

Therapeutics: siRNAs jump the hurdle.

Sarah Seton-Rogers.   

Abstract

Year:  2012        PMID： 22576164     DOI： 10.1038/nrc3281

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis.

Authors:  Yan-dan Yao; Tian-meng Sun; Song-yin Huang; Shuang Dou; Ling Lin; Jia-ning Chen; Jian-bin Ruan; Cheng-qiong Mao; Feng-yan Yu; Mu-sheng Zeng; Jian-ye Zang; Qiang Liu; Feng-xi Su; Peter Zhang; Judy Lieberman; Jun Wang; Erwei Song
Journal:  Sci Transl Med       Date:  2012-04-18       Impact factor: 17.956
  1 in total
  8 in total

Review 1.  Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy.

Authors:  Anish Babu; Ranganayaki Muralidharan; Narsireddy Amreddy; Meghna Mehta; Anupama Munshi; Rajagopal Ramesh
Journal:  IEEE Trans Nanobioscience       Date:  2016-12       Impact factor: 2.935

2.  Use of polymeric CXCR4 inhibitors as siRNA delivery vehicles for the treatment of acute myeloid leukemia.

Authors:  Yiqian Wang; Ying Xie; Jacob Williams; Yu Hang; Lisa Richter; Michelle Becker; Catalina Amador; David Oupický; R Katherine Hyde
Journal:  Cancer Gene Ther       Date:  2019-04-26       Impact factor: 5.987

3.  shRNA-Mediated Silencing of Y-Box Binding Protein-1 (YB-1) Suppresses Growth of Neuroblastoma Cell SH-SY5Y In Vitro and In Vivo.

Authors:  Hong Wang; Ruowen Sun; Min Gu; Shuang Li; Bin Zhang; Zuofei Chi; Liangchun Hao
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

4.  High Expression of the Newly Found Long Noncoding RNA Z38 Promotes Cell Proliferation and Oncogenic Activity in Breast Cancer.

Authors:  Rilin Deng; Bin Liu; Yan Wang; Feng Yan; Shifan Hu; Hongcan Wang; Tingting Wang; Bin Li; Xiyun Deng; Shuanglin Xiang; Yinke Yang; Jian Zhang
Journal:  J Cancer       Date:  2016-03-18       Impact factor: 4.207

Review 5.  Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic target.

Authors:  Pramod Kumar Maurya; Alok Mishra; Birendra Singh Yadav; Swati Singh; Prashant Kumar; Amit Chaudhary; Shweta Srivastava; Suriya Narayan Murugesan; Ashutosh Mani
Journal:  J Cancer       Date:  2017-07-03       Impact factor: 4.207

Review 6.  Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma.

Authors:  Thomas G Johnson; Karin Schelch; Sunali Mehta; Andrew Burgess; Glen Reid
Journal:  Front Cell Dev Biol       Date:  2019-10-01

7.  Self-assembling asymmetric peptide-dendrimer micelles - a platform for effective and versatile in vitro nucleic acid delivery.

Authors:  Ganesh R Kokil; Rakesh N Veedu; Bao Tri Le; Grant A Ramm; Harendra S Parekh
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

8.  Fisetin targets YB-1/RSK axis independent of its effect on ERK signaling: insights from in vitro and in vivo melanoma models.

Authors:  Mario Sechi; Rahul K Lall; Saheed O Afolabi; Anant Singh; Dinesh C Joshi; Shing-Yan Chiu; Hasan Mukhtar; Deeba N Syed
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.